Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis (Q35120602)

6 August 2017

Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis (English)

1 reference

6 August 2017

1 reference

1 reference

1 reference

Andrés Guillermo Lescano

Andres G Lescano

2

0 references

Vera Lucia Lanchote

Vera L Lanchote

Armando Emiliano González

3

0 references

Armando E Gonzalez

Cysticercosis Working Group in Peru

11

0 references

13

Cysticercosis Working Group in Peru

1 reference

6 August 2017

12

Robert H Gilman

1 reference

6 August 2017

1

Hector H Garcia

1 reference

6 August 2017

E Javier Pretell

4

1 reference

6 August 2017

Isidro Gonzales

5

1 reference

6 August 2017

Javier A Bustos

6

1 reference

6 August 2017

Osvaldo M Takayanagui

7

1 reference

6 August 2017

Pierina S Bonato

8

1 reference

6 August 2017

John Horton

9

1 reference

6 August 2017

Herbert Saavedra

10

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

British Journal of Clinical Pharmacology

6 August 2017

1 reference

6 August 2017

72

1 reference

6 August 2017

1

1 reference

6 August 2017

77-84

1 reference

Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Drug interactions between chemotherapeutic regimens and antiepileptics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Pharmacokinetic interaction between ketoconazole and praziquantel in healthy volunteers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Clinically relevant drug interactions with antiepileptic drugs

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

A combined medical and surgical approach to hydatid disease: 12 years' experience at the Hospital for Tropical Diseases, London.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Bioavailability of praziquantel increases with concomitant administration of food

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Albendazole treatment of echinococcosis in humans: effects on microsomal metabolism and drug tolerance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Relationship Between Epilepsy and Tropical Diseases

28 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Imaging Features of Disseminated Peritoneal Hydatidosis Before and After Medical Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Response of multiorganic hydatdosis to combined therapy with albendazoleand praziquantel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Cutaneous larva migrans associated with Löffler's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Influence of a Mexican diet on the bioavailability of albendazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2011.03945.X

Population pharmacokinetics of albendazole in patients with neurocysticercosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Therapeutic efficacy of praziquantel, albendazole and a combination of the two drugs in cysticercosis

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3141188

Medical decompression of vertebral hydatidosis

27 September 2018

1 reference

12 December 2020

Combination chemotherapy is more effective in postspillage prophylaxis for hydatid disease than either albendazole or praziquantel alone

1 reference

12 December 2020

The metabolism of benzimidazole anthelmintics

1 reference

12 December 2020

[Efficacy of praziquantel combined with albendazole in the treatment of clonorchiasis]

1 reference

12 December 2020

Phenytoin and carbamazepine decreased oral bioavailability of praziquantel

1 reference

12 December 2020

Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography–electrospray mass spectrometry

1 reference

12 December 2020

Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy

1 reference

12 December 2020

10.1111/J.1365-2125.2011.03945.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

6 August 2017

1 reference